American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Becton Dickinson
BDX
|
+$389M |
| 2 |
Meta Platforms (Facebook)
META
|
+$296M |
| 3 |
Salesforce
CRM
|
+$207M |
| 4 |
Howmet Aerospace
HWM
|
+$122M |
| 5 |
Reinsurance Group of America
RGA
|
+$121M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$349M |
| 2 |
Visa
V
|
+$249M |
| 3 |
IQVIA
IQV
|
+$234M |
| 4 |
T-Mobile US
TMUS
|
+$226M |
| 5 |
NXP Semiconductors
NXPI
|
+$212M |
Sector Composition
| 1 | Technology | 23.35% |
| 2 | Healthcare | 13.84% |
| 3 | Financials | 13.36% |
| 4 | Consumer Discretionary | 11.5% |
| 5 | Industrials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Kiniksa Pharmaceuticals
KNSA
$2.71B
| $158K | ﹤0.01% |
+11,205
| New | +$158K |
|
|
ROVR
2552
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $155K | ﹤0.01% |
31,582
+3,202
| +11% | +$15.7K |
|
2553
Blue Foundry Bancorp
BLFY
$203M
| $153K | ﹤0.01% |
+15,098
| New | +$153K |
|
2554
Adtran
ADTN
$830M
| $152K | ﹤0.01% |
+14,450
| New | +$152K |
|
2555
Lifecore Biomedical
LFCR
$273M
| $151K | ﹤0.01% |
+15,578
| New | +$151K |
|
2556
Butterfly Network
BFLY
$400M
| $150K | ﹤0.01% |
65,033
+27,508
| +73% | +$63.3K |
|
2557
McEwen Inc.
MUX
$734M
| $148K | ﹤0.01% |
+20,622
| New | +$148K |
|
2558
KalVista Pharmaceuticals
KALV
$786M
| $148K | ﹤0.01% |
+16,446
| New | +$148K |
|
2559
Oric Pharmaceuticals
ORIC
$1.02B
| $147K | ﹤0.01% |
+18,959
| New | +$147K |
|
|
NXDR
2560
Nextdoor Holdings
NXDR
$778M
| $147K | ﹤0.01% |
45,003
+32,058
| +248% | +$105K |
|
2561
PetMed Express
PETS
$58.9M
| $146K | ﹤0.01% |
+10,596
| New | +$146K |
|
2562
Zegna
ZGN
$2.29B
| $145K | ﹤0.01% |
+11,422
| New | +$145K |
|
2563
3D Systems Corporation
DDD
$269M
| $143K | ﹤0.01% |
+14,384
| New | +$143K |
|
2564
TaskUs
TASK
$1.64B
| $140K | ﹤0.01% |
+12,326
| New | +$140K |
|
|
SHCR
2565
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $139K | ﹤0.01% |
79,279
| – | – |
|
2566
AngioDynamics
ANGO
$443M
| $138K | ﹤0.01% |
+13,270
| New | +$138K |
|
2567
SiriusXM
SIRI
$8.17B
| $137K | ﹤0.01% |
3,015
+26
| +0.9% | +$1.18K |
|
|
SBT
2568
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $136K | ﹤0.01% |
24,862
-2,554
| -9% | -$14K |
|
|
API
2569
Agora
API
$334M
| $136K | ﹤0.01% |
43,313
| – | – |
|
2570
Repare Therapeutics
RPTX
$73.5M
| $135K | ﹤0.01% |
+12,730
| New | +$135K |
|
2571
Chegg
CHGG
$168M
| $134K | ﹤0.01% |
15,061
-10,907
| -42% | -$96.9K |
|
|
FPI
2572
Farmland Partners
FPI
$471M
| $133K | ﹤0.01% |
10,927
+844
| +8% | +$10.3K |
|
2573
Stitch Fix
SFIX
$744M
| $133K | ﹤0.01% |
34,512
+23,584
| +216% | +$90.8K |
|
2574
Sutro Biopharma
STRO
$83.3M
| $133K | ﹤0.01% |
28,507
+13,851
| +95% | +$64.4K |
|
2575
Liberty Latin America Class A
LILA
$1.57B
| $131K | ﹤0.01% |
+15,006
| New | +$131K |
|